Literature DB >> 19932662

Do differences in pegylation of interferon alfa matter?

Stefan Zeuzem.   

Abstract

Mesh:

Substances:

Year:  2009        PMID: 19932662     DOI: 10.1053/j.gastro.2009.11.034

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  6 in total

1.  Which is the IDEAL peginterferon for Hepatitis C: a meta-analysis of both pegylated interferons in the treatment of HCV-infected patients.

Authors:  Frank Tacke
Journal:  Hepat Mon       Date:  2010-09-01       Impact factor: 0.660

Review 2.  Pegylated interferons alpha2a and alpha2b in the treatment of chronic hepatitis C.

Authors:  Alessio Aghemo; Maria Grazia Rumi; Massimo Colombo
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-07-20       Impact factor: 46.802

3.  Evolution of interferon-based therapy for chronic hepatitis C.

Authors:  Chun-Hao Chen; Ming-Lung Yu
Journal:  Hepat Res Treat       Date:  2010-10-10

4.  Pegylated interferon alfa and ribavirin for children with chronic hepatitis C.

Authors:  Irit Rosen; Michal Kori; Orly Eshach Adiv; Baruch Yerushalmi; Nataly Zion; Ron Shaoul
Journal:  World J Gastroenterol       Date:  2013-02-21       Impact factor: 5.742

5.  Thyroid disease is a favorable prognostic factor in achieving sustained virologic response in chronic hepatitis C undergoing combination therapy: A nested case control study.

Authors:  Huy A Tran; Tracey L Jones; Robert Gibson; Glenn Em Reeves
Journal:  BMC Endocr Disord       Date:  2011-05-24       Impact factor: 2.763

6.  Pegylated interferon monotherapy for hepatitis C virus infection in patients on hemodialysis: A single center study.

Authors:  S K Agarwal; D Bhowmik; S Mahajan; S Bagchi
Journal:  Indian J Nephrol       Date:  2016 Jul-Aug
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.